Literature DB >> 23667173

miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.

Elisa Penna1, Francesca Orso, Daniela Cimino, Irene Vercellino, Elena Grassi, Elena Quaglino, Emilia Turco, Daniela Taverna.   

Abstract

Malignant melanoma is one of the most aggressive human cancers, but the mechanisms governing its metastatic dissemination are not fully understood. Upregulation of miR-214 and ALCAM and the loss of TFAP2 expression have been implicated in this process, with TFAP2 a direct target of miR-214. Here, we link miR-214 and ALCAM as well as identify a core role for miR-214 in organizing melanoma metastasis. miR-214 upregulated ALCAM, acting transcriptionally through TFAP2 and also posttranscriptionally through miR-148b (itself controlled by TFAP2), both negative regulators of ALCAM. We also identified several miR-214-mediated prometastatic functions directly promoted by ALCAM. Silencing ALCAM in miR-214-overexpressing melanoma cells reduced cell migration and invasion without affecting growth or anoikis in vitro, and it also impaired extravasation and metastasis formation in vivo. Conversely, cell migration and extravasation was reduced in miR-214-overexpressing cells by upregulation of either miR-148b or TFAP2. These findings were consistent with patterns of expression of miR-214, ALCAM, and miR-148b in human melanoma specimens. Overall, our results define a pathway involving miR-214, miR-148b, TFAP2, and ALCAM that is critical for establishing distant metastases in melanoma. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23667173     DOI: 10.1158/0008-5472.CAN-12-3686

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

Review 2.  microRNA Regulation of Skeletal Development.

Authors:  Steven R Sera; Nicole I Zur Nieden
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

Review 3.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

Review 4.  MicroRNAs: master regulators of drug resistance, stemness, and metastasis.

Authors:  Umar Raza; Jitao David Zhang; Ozgür Sahin
Journal:  J Mol Med (Berl)       Date:  2014-02-09       Impact factor: 4.599

5.  Evolution of the miR199-214 cluster and vertebrate skeletal development.

Authors:  Thomas Desvignes; Adam Contreras; John H Postlethwait
Journal:  RNA Biol       Date:  2014-02-20       Impact factor: 4.652

6.  Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.

Authors:  Barbara Fontanals-Cirera; Dan Hasson; Chiara Vardabasso; Raffaella Di Micco; Praveen Agrawal; Asif Chowdhury; Madeleine Gantz; Ana de Pablos-Aragoneses; Ari Morgenstern; Pamela Wu; Dan Filipescu; David Valle-Garcia; Farbod Darvishian; Jae-Seok Roe; Michael A Davies; Christopher R Vakoc; Eva Hernando; Emily Bernstein
Journal:  Mol Cell       Date:  2017-11-16       Impact factor: 17.970

7.  Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.

Authors:  Andrea R Hallberg; Sabine U Vorrink; Danielle R Hudachek; Kimberly Cramer-Morales; Mohammed M Milhem; Robert A Cornell; Frederick E Domann
Journal:  Epigenetics       Date:  2014-12       Impact factor: 4.528

8.  Photocontrolled miR-148b nanoparticles cause apoptosis, inflammation and regression of Ras induced epidermal squamous cell carcinomas in mice.

Authors:  Yiming Liu; Jacob T Bailey; Mohammad Abu-Laban; Shue Li; Cong Chen; Adam B Glick; Daniel J Hayes
Journal:  Biomaterials       Date:  2020-06-22       Impact factor: 12.479

Review 9.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

Review 10.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.